| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 2.839 | 6.409 | 5.930 |
| Total Income - EUR | - | - | - | 2.655 | 6.881 | 185 | 21.681 | 17.732 | 10.739 | 11.157 |
| Total Expenses - EUR | - | - | - | 2.655 | 6.881 | 185 | 23.781 | 23.467 | 10.343 | 11.015 |
| Gross Profit/Loss - EUR | - | - | - | 0 | 0 | 0 | -2.100 | -5.735 | 396 | 143 |
| Net Profit/Loss - EUR | - | - | - | 0 | 0 | 0 | -2.100 | -5.820 | 396 | 143 |
| Employees | - | - | - | 1 | 1 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Pro Kinevsia Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 2.584 | 26.193 | 40.216 | 38.072 | 35.849 |
| Current Assets | - | - | - | 33.394 | 25.128 | 22.502 | 18.106 | 15.592 | 599 | 883 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 14.126 | 14.170 | 67 | 66 |
| Cash | - | - | - | 33.394 | 25.128 | 22.502 | 3.980 | 1.422 | 532 | 817 |
| Shareholders Funds | - | - | - | 43 | 42 | 41 | -2.060 | -7.886 | -7.466 | -7.281 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 968 | 211 | 827 | 6.567 | 24.392 | 8.976 | 9.094 |
| Income in Advance | - | - | - | 32.383 | 24.875 | 24.218 | 39.792 | 39.302 | 37.161 | 34.943 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Pro Kinevsia Med S.r.l.